SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-315863
Filing Date
2020-12-11
Accepted
2020-12-11 16:02:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d70609ds3.htm S-3 327024
2 EX-4.3 d70609dex43.htm EX-4.3 30711
3 EX-4.4 d70609dex44.htm EX-4.4 254348
4 EX-5.1 d70609dex51.htm EX-5.1 31747
5 EX-23.1 d70609dex231.htm EX-23.1 1653
6 GRAPHIC g70609g11s30.jpg GRAPHIC 49887
7 GRAPHIC g70609g1210072716818.jpg GRAPHIC 6100
  Complete submission text file 0001193125-20-315863.txt   724090
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251294 | Film No.: 201383597
SIC: 2834 Pharmaceutical Preparations